| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/11/1994 | WO1994010139A1 Novel vitamin d analogues |
| 05/11/1994 | WO1994010118A1 Tri-substituted phenyl derivatives and processes for their preparation |
| 05/11/1994 | WO1994009824A1 Allergenic extracts |
| 05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | WO1994009818A1 Method for stimulating production of variable region gene family restricted antibodies through b-cell superantigen vaccination |
| 05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 05/11/1994 | WO1994009803A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 05/11/1994 | WO1994009799A1 Anti-inflammatory factor, method of isolation, and use |
| 05/11/1994 | WO1994009793A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 05/11/1994 | WO1994009791A1 Fludarabine-5'-monophosphate for the treatment of autoimmune diseases |
| 05/11/1994 | EP0596717A1 Nutritional supplement for the elderly |
| 05/11/1994 | EP0596406A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists |
| 05/11/1994 | EP0596355A1 Method for the assay of enkephalinase |
| 05/11/1994 | EP0596032A1 Induction of cytotoxic t-lymphocyte responses |
| 05/11/1994 | EP0595989A1 Benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | EP0595855A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/11/1994 | CN1086543A CDNA clones coding for polypepstides exhibiting human granulocyte macrophage and eosinophie cellular growth |
| 05/11/1994 | CA2148620A1 Indolylcarbamates as anti-inflammatory agents |
| 05/11/1994 | CA2148247A1 Rapamycin arylcarbonyl and alkoxycarbonyl as immunosuppressive and antifungal agents |
| 05/11/1994 | CA2148007A1 Allergenic extracts |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2146767A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | CA2144161A1 Novel vitamin d analogues |
| 05/11/1994 | CA2143489A1 Transformed endothelial cells |
| 05/11/1994 | CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/10/1994 | US5310959 Reacting 1-decyne with 1,4-dihalo-2-butyne using a strong base and then reacting with 5-hexynoic acid; reacting with an amine in the presense of carbonyldiimidazole to amidate |
| 05/10/1994 | US5310744 Quinolylmethoxyphenyl-acetamides |
| 05/10/1994 | US5310732 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis |
| 05/10/1994 | CA1329390C Anti-inflammatory furanones |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595133A2 Prodrugs, their preparation and use as medicaments |
| 05/04/1994 | EP0595006A1 Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
| 05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594702A1 Substituted indoles as anti-aids pharmaceuticals. |
| 05/04/1994 | EP0594636A1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 05/04/1994 | EP0594602A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| 05/04/1994 | EP0594600A1 Immunosuppressive macrocyclic compounds |
| 05/03/1994 | US5308852 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308850 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308847 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
| 05/03/1994 | US5308840 Substituted or unsubstituted benzhydryl heteroalkyl-substituted aminophenol compounds and pharmaceutical compositions thereof |
| 05/03/1994 | US5308618 Dietary fiber extracted from wheat bran pharmaceutical and dietary compositions containing same |
| 05/03/1994 | CA2102137A1 Heterocyclic compounds |
| 05/03/1994 | CA1329119C Cytotoxic therapy |
| 05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
| 04/28/1994 | WO1994009138A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 04/28/1994 | WO1994008996A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/28/1994 | WO1994008619A1 Treatment of autoimmune and inflammatory disorders |
| 04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 04/28/1994 | WO1994008574A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2147466A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
| 04/28/1994 | CA2146988A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2146261A1 Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/27/1994 | EP0593761A1 New thiophene derivatives |
| 04/27/1994 | EP0593559A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 04/27/1994 | EP0593461A1 3-substituted-1-(aryl or arylalkyl)-2(1h)-quinolinones |
| 04/27/1994 | EP0485471B1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
| 04/27/1994 | EP0460032B1 Novel vitamin d analogues |
| 04/27/1994 | EP0422097B1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
| 04/27/1994 | CN1085899A 7-(2-aminoethyl)-benzothiazolones |
| 04/27/1994 | CN1085894A Antiinflammatory indolinyl N-hydroxyurea and N-hydroxamic acid derivatives |
| 04/26/1994 | CA1328808C Active agent and pharmaceutical composition containing such, for preventing and controlling human transplant rejection |
| 04/20/1994 | EP0592791A2 Tricyclic compounds and peptide derivatives thereof |
| 04/20/1994 | EP0592582A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 04/20/1994 | EP0430983B1 Use of castanospermine as an anti-inflammatory and immunosuppressant agent |
| 04/20/1994 | EP0408711B1 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/19/1994 | US5304634 From culturing macrophages or mononuclear phagocytes from liposaccharide-tolerant vertebrates |
| 04/19/1994 | US5304560 Treating CNS disorders; dopamine receptor antagonist |
| 04/19/1994 | CA1328601C Preparation of t-cell and t-cell membrane for use in autoimmune diseases |
| 04/14/1994 | WO1994008008A1 Improvements in or relating to immune response modification |
| 04/14/1994 | WO1994007921A1 Target binding polypeptide |
| 04/14/1994 | WO1994007853A1 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 04/14/1994 | WO1994007852A1 Novel vitamin d analogues |
| 04/14/1994 | WO1994007851A1 Novel vitamin d analogues |
| 04/14/1994 | WO1994007517A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | WO1994007516A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | WO1994007495A1 Use of norastemizole for the treatment of allergic disorders |
| 04/14/1994 | WO1994007479A2 Immunopotentiatory agents |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | CA2145762A1 Pp14-based therapy |
| 04/14/1994 | CA2144850A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | CA2136451A1 Novel vitamin d analogues |
| 04/13/1994 | EP0591320A1 Suppressor t-cell hybridoma |
| 04/13/1994 | EP0591281A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 04/13/1994 | EP0591256A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
| 04/13/1994 | EP0591254A1 Immunosuppressive and tolerogenic modified lewis?x and lewis?a compounds |
| 04/12/1994 | US5302718 Compounds containing an amino salicylic acid moiety linked to a sulphapyridine moiety via stable bridge |
| 04/12/1994 | US5302597 Enzyme inhibitors |
| 04/12/1994 | US5302596 Tricyclic compounds as TXA2 antagonists |
| 04/12/1994 | US5302594 5-lipoxygenase inhibitors quinoxalinyl derivatives |
| 04/12/1994 | US5302590 Compounds useful as dual antagonists of platelet activating factor and leukotriene D4 |
| 04/12/1994 | US5302584 Carbamates of rapamycin |
| 04/12/1994 | CA1328465C Eicosanoid sulfides and their application as pharmaceutical and cosmetic compounds |